A biotech stock focused on GLP-1 could challenge Novo Nordisk.
It’s likely that you’ve heard of Novo Nordisk’s medications such as Ozempic and Wegovy, even if you don’t entirely grasp their technical details.
A biotech stock focused on GLP-1 could challenge Novo Nordisk. Read More »